Test-retest repeatability of quantitative cardiac 11C-meta-hydroxyephedrine measurements in rats by small animal positron emission tomography

Nuclear Medicine and Biology

Volumn 40, Issue 5, 2013, Pages 676-681

  Thackeray, James T ^a,b,c   Renaud, Jennifer M ^a   Kordos, Myra ^a   Klein, Ran ^a   DeKemp, Robert A ^a   Beanlands, Rob S B ^a,b   DaSilva, Jean N ^a,b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

PET; Cardiac disease; HED; Norepinephrine; Sympathetic neuronal imaging

Indexed keywords

3 HYDROXYEPHEDRINE C 11; DESIPRAMINE; NORADRENALIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CARDIAC IMAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG RESPONSE; DRUG RETENTION; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MEASUREMENT REPEATABILITY; NONHUMAN; NORADRENALIN BLOOD LEVEL; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; DESIPRAMINE; EPHEDRINE; HEART; MALE; MYOCARDIUM; NOREPINEPHRINE; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS;

EID: 84878181855     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2013.03.007     Document Type: Article

References (29)

1. Bengel F.M. Clinical cardiovascular molecular imaging. J Nucl Med 2009, 50:837-840.
2. Allman K.C., Wieland D.M., Muzik O., Degrado T.R., Wolfe E.R., Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol 1993, 22:368-375.
3. Ungerer M., Weig H.J., Kubert S., Overbeck M., Bengel F., Schomig A., et al. Regional pre- and postsynaptic sympathetic system in the failing human heart - regulation of beta ARK-1. Eur J Heart Fail 2000, 2:23-31.
4. Bulow H.P., Stahl F., Lauer B., Nekolla S.G., Schuler G., Schwaiger M., et al. Alterations of myocardial presynaptic sympathetic innervation in patients with multi-vessel coronary artery disease but without history of myocardial infarction. Nucl Med Commun 2003, 24:233-239.
5. Link J.M., Stratton J.R., Levy W., Poole J.E., Shoner S.C., Stuetzle W., et al. PET measures of pre- and post-synaptic cardiac beta adrenergic function. Nucl Med Biol 2003, 30:795-803.
6. Ungerer M., Hartmann F., Karoglan M., Chlistalla A., Ziegler S., Richardt G., et al. Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation 1998, 97:174-180.
7. Rosenspire K.C., Haka M.S., Van Dort M.E., Jewett D.M., Gildersleeve D.L., Schwaiger M., et al. Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nucl Med 1990, 31:1328-1334.
8. Raffel D., Wieland D. Assessment of cardiac sympathetic nerve integrity with positron emission tomography. Nucl Med Biol 2001, 28:541-559.
9. Thackeray J.T., Beanlands R.S., Dasilva J.N. Presence of specific 11C-meta-hydroxyephedrine retention in heart, lung, pancreas, and brown adipose tissue. J Nucl Med 2007, 48:1733-1740.
10. Law M.P., Osman S., Davenport R.J., Cunningham V.J., Pike V.W., Camici P.G. Biodistribution and metabolism of [N-methyl-11C]m-hydroxyephedrine in the rat. Nucl Med Biol 1997, 24:417-424.
11. Hartmann F., Ziegler S., Nekolla S., Hadamitzky M., Seyfarth M., Richardt G., et al. Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography. Heart 1999, 81:262-270.
12. deGrado T.R., Hutchins G., SA T., DM W., M S. Myocardial kinetics of carbon-11-meta-hydroxyephedrine: retention mechanisms and effects of norepinephrine. J Nucl Med 1993, 34:1287-1293.
13. Tipre D.N., Fox J.J., Holt D.P., Green G., Yu J., Pomper M., et al. In vivo PET imaging of cardiac presynaptic sympathoneuronal mechanisms in the rat. J Nucl Med 2008, 49:1189-1195.
14. Law M.P., Schafers K., Kopka K., Wagner S., Schober O., Schafers M. Molecular imaging of cardiac sympathetic innervation by 11C-mHED and PET: from man to mouse?. J Nucl Med 2010, 51:1269-1276.
15. Klein R., Beanlands R.S., deKemp R.A. Quantification of myocardial blood flow and flow reserve: technical aspects. J Nucl Cardiol 2010, 17:555-570.
16. Yoshinaga K., Burwash I.G., Leech J.A., Haddad H., Johnson C.B., deKemp R., et al. The effect of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea. JACC 2007, 49:450-458.
17. Thackeray J.T., Radziuk J., Harper M.E., Suuronen E.J., Ascah K.J., Beanlands R.S., et al. Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemia. Cardiovasc Diabetol 2011, 10:75.
18. Aznavour N., Benkelfat C., Gravel P., Aliaga A., Rosa-Neto P., Bedell B., et al. MicroPET imaging of 5-HT 1A receptors in rat brain: a test-retest [18F]MPPF study. Eur J Nucl Med Mol Imaging 2009, 36:53-62.
19. Thomas A.J., DaSilva J.N., Lortie M., Renaud J.M., Kenk M., Beanlands R.S., et al. PET of (R)-11C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart. J Nucl Med 2011, 52:263-269.
20. Raffel D.M., Chen W., Sherman P.S., Gildersleeve D.L., Jung Y.W. Dependence of cardiac 11C-meta-hydroxyephedrine retention on norepinephrine transporter density. J Nucl Med 2006, 47:1490-1496.
21. Matsunari I., Aoki H., Nomura Y., Takeda N., Chen W.P., Taki J., et al. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Circ Cardiovasc Imaging 2010, 3:595-603.
22. Raffel D.M., Chen W. Binding of [3H]mazindol to cardiac norepinephrine transporters: kinetic and equilibrium studies. Naunyn Schmiedebergs Arch Pharmacol 2004, 370:9-16.
23. Mandela P., Ordway G.A. The norepinephrine transporter and its regulation. J Neurochem 2006, 97:310-333.
24. Shimizu S., Akiyama T., Kawada T., Shishido T., Mizuno M., Kamiya A., et al. In vivo direct monitoring of interstitial norepinephrine levels at the sinoatrial node. Auton Neurosci 2009.
25. Raymon H.K., Leslie F.M. Opioid effects on [3H]norepinephrine release from dissociated embryonic locus coeruleus cell cultures. J Neurochem 1994, 62:1015-1024.
26. Rundqvist B., Elam M., Bergmann-Sverrisdottir Y., Eisenhofer G., Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 1997, 95:169-175.
27. Bristow M.R., Krause-Steinrauf H., Nuzzo R., Liang C.S., Lindenfeld J., Lowes B.D., et al. Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial. Circulation 2004, 110:1437-1442.
28. Sasano T., Abraham M.R., Chang K.C., Ashikaga H., Mills K.J., Holt D.P., et al. Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 2008, 51:2266-2275.
29. Luisi A.J., Fallavollita J.A., Suzuki G., deKemp R., Haka M.S., Toorongian S.A., et al. Regional 11C-hydroxyephedrine uptake in hibernating myocardium: chronic inhomogeneity of sympathetic innervation in the absence of infarction. J Nucl Med 2005, 46:1368-1374.